Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Astellas Pharma Korea, Inc.

Clinical trials sponsored by Astellas Pharma Korea, Inc., explained in plain language.

Now part of Astellas Pharma Inc. 4503 TOKYO

Korean subsidiary of Astellas Pharma, a global pharmaceutical company.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1

New drug combo offers hope for men with stubborn prostate symptoms

Disease control Not yet recruiting

This study follows 600 men in South Korea with moderate to severe enlarged prostate symptoms that tamsulosin alone didn't control well. Researchers will track side effects and symptom improvement over 24 weeks of treatment with Vesomni, a combination tablet. The goal is to see ho…

Sponsor: Astellas Pharma Korea, Inc. • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC